when will tirzepatide go generic Mounjaro availability (2026) Tirzepatide, the active ingredient behind

(Source: VCU Health, 2026) Semaglutide Linked to Lower Dementia Risk in 1.7 Million Patient Study A June 2025 study from Case Western Reserve University involving 1.7 million patients found a stunning link between semaglutide use and lower dementia risk

Last year, the FDA approved the first medication for MASH, Rezdiffra (resmetirom), but management still largely relies on lifestyle changes such as diet, exercise and weight loss

A.JayaramanM.MatsudaS.LiuJ.BarrosS.QuerbesW.et al (2021)

Both medications were first developed and approved for type 2 diabetes , and both produce meaningful reductions in HbA1c (a marker of average blood glucose over roughly three months)